JAK2V617F - Globe Thesis

Keyword [JAK2V617F] Result: 21 - 40 \| Page: 2 of 4
21.	The Investigation And Clinical Significance Of JAK2V617F Mutation In Myeloproliferative Neoplasm Patients
22.	Splanchnic Vein Thrombosis In China: Etiology And Treatment With Transjugular Intrahepatic Portosystemic Shunt
23.	Study On The Relationship Between JAK2V617F Gene Mutation And Clinical Characteristics Of BCR/ABL Negative Myeloproliferative Neoplasms
24.	JAK2V617F Mutation Testing In Myeloproliferative Neoplasms
25.	Research On Biological Characteristics Of Bone Marrow Mesenchymal Stem Cells And JAK2Mutation In Myeloproliferative Neoplasms
26.	Effect Of Epidermal Growth Factor Receptor Inhibitor On Proliferation Of JAK2V617F-positive Cells In Vitro
27.	Correlative Study Between JAK2V617F Mutation And Thrombosis In Patients With Myeloproliferative Neoplasm
28.	Quantitative Determination Of JAK2V617F Mutation And P-STAT5in The Patients With Myeloproliferative Neoplasm And Their Relations With Clinic Features
29.	The Analysis Of JAK2V617F In Myeloproliferative Neoplasms And Its Correlation With MPL
30.	Study On Detection Methods For JAK2V617F Mutation Gene In Myeloproliferative Disorders
31.	Clinical Analysis Of208Cases Of BCR/ABL Negative Myeloproliferative Neoplasms
32.	The Research Of Cardiac Hypertrophy Associated With Myeloproliferative Neoplasms In JAK2V617F Transgenic Mice
33.	The Clinical Significant Of The Detection Of JAK2V617F Point Mutations In Meloproferative Neoploasms Patients
34.	Changes Of ADAMTS13Activity And VWF Antigen In Patients With Acute Myelogenous Leukemia; Clinical Significance Of Circulating Microparticles In Ph-myeloproliferative Neoplasms (MPN)
35.	Application Of Melting Curve Analysis Derived Techniques:Detection Of JAK2V617F Mutation In Myeloproliferative Neoplasms
36.	The Clinical Significance Of Cereblon Expression In Chronic Myeloproliferative Neoplasma
37.	The Impact Of Autophagy Regulation On Proliferation Of HEL Cells And Hematopoietic Cells Of Polycythemia Vera Patients With JAK2 V617F Mutation
38.	Mutation Analysis Of JAK2V617F, DNMT3A, NPM1 And FLT3-ITD In Myeloproliferative Neoplasms
39.	The Study Of Expression And Co-relation Between The JAK2V617F And IL-6, TNF-Î±, IL-32, IL-37 In Myeloproliferative Neoplasms
40.	Clinical Relevance Of JAK2 And CALR Mutation In Patients With BCR-ABL Negative Myeloproliferative Neoplasms
<<First <Prev Next> Last>> Jump to